Abstract
Background
Hepatocellular carcinoma (HCC) with bile duct tumor thrombi (BDTT) is a rare type of primary liver cancer, and its clinical and pathological characteristics remain to be defined.
Aims
To investigate the clinical and pathological characteristics of HCC with BDTT.
Methods
Among 676 HCC patients who underwent surgical treatment from Dec. 2002 to Dec. 2008 at the author’s hospital, HCC with BDTT was identified in 20 patients. The clinical and pathological characteristics of the 20 patients were measured or analyzed retrospectively. The integrity of the involved bile duct was examined macroscopically and microscopically, the expression of liver stem cell markers was investigated by immunohistochemistry, and the Kaplan–Meier method was adopted for evaluating survival.
Results
Among the 20 patients, the diameter of the primary tumor was less than 5 cm in 13 patients (range: 0.5–10 cm, mean 4.47 ± 0.68 cm). Most of the primary tumors lacked an intact tumor capsule (15/20, 75%), had simultaneous blood vessel invasion (12/20, 60%), and were poorly differentiated (13/20, 65%). There was no evidence of bile duct wall infiltration by the tumor cells macroscopically or microscopically. The positive rate of the liver stem cell markers c-kit, CD90, CD133, and EpCAM was 90, 90, 85 and 85%, respectively. Postoperative overall survival rates at 1, 2, and 3 years were 73.1, 41.1, and 20.6%, respectively. The log-rank test showed that the overall survival rates were significantly worse for HCC patients with BDTT than for HCC patients without BDTT (P = 0.016).
Conclusions
HCC with BDTT has aggressive characteristics and the long-term prognosis is extremely dismal.
Similar content being viewed by others
References
El-Serag HB, Rudolph L. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.
Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917.
Kojiro M, Kawabata K, Kawano Y, et al. Hepatocellular-carcinoma presenting as intra-bile duct tumor-growth—a clinicopathologic study of 24 cases. Cancer. 1982;49:2144–2147.
Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol. 2003;9:385–391.
Liu Q, Chen J, Li H, et al. Hepatocellular carcinoma with bile duct tumor thrombi: Correlation of magnetic resonance imaging features to histopathologic manifestations. Eur J Radiol. 2009.
Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: Aggressive operative approach after appropriate preoperative management. Surgery. 2001;129:692–698.
Peng SY, Wang JW, Liu YB, et al. Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg. 2004;28:43–46.
Peng B-G, Liang L-J, Li S-Q, et al. Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World J Gastroenterol. 2005;11:3966–3969.
Qin L-X, Ma Z-C, Wu Z-Q, et al. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: Experience of 34 patients. World J Gastroenterol. 2004;10:1397–1401.
American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer; 2002:145–149.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca-a Cancer J Clin. 2005;55:74–108.
Shirabe K, Kajiyama K, Harimoto N. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol. 2009;15:2632–2637.
Mallory TB, Castleman B, Parris EE. Case records of the Massachusetts General Hospital. N Eng J Med. 1947;237:673–676.
Lin TY, Chen KM, Chen YR. Icteric type hepatoma. Med Chir Dig. 1975;4:267–270.
Tseng JH, Hung CF, Ng KK. Icteric-type hepatoma: Magnetic resonance imaging and magnetic resonance cholangiographic features. Abdom Imaging. 2001;26:171–177.
Buckmaster MJ, Schwartz RW, Carnahan GE, Strodel WE. Hepatocellular-carcinoma embolus to the common hepatic duct with no detectable primary hepatic tumor. Am Surg. 1994;60:699–702.
Yeh CN, Jan YY, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg. 2004;28:471–474.
Huang GT, Sheu JC, Lee HS, et al. Icteric type hepatocellular carcinoma: Revisited 20 years later. J Gastroenterol. 1998;33:53–56.
Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery. 2000;128:779–783.
Huang JF, Wang LY, Lin ZY, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17:190–195.
Edmondson HA, Steiner PE. Primary carcinoma of the liver—a study of 100 cases among 48, 900 necropsies. Cancer. 1954;7:462–503.
Narita R, Oto T, Mimura Y, et al. Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma. J Gastroenterol. 2002;37:55–58.
Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg. 2009;13:492–497.
Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 2001;33:738–750.
Yamashita T, Forgues M, Wang W, et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008;68:1451–1461.
Papoulas M, Theocharis S. Primary liver tumors: Origin and target therapy. Expert Opin Ther Targets. 2009;13:957–965.
Liu C, Schreiter T, Dirsch O, et al. Presence of markers for liver progenitor cells in human-derived intrahepatic biliary epithelial cells. Liver Int. 2004;24:669–678.
Mishra L, Banker T, Banker T, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318–329.
Acknowledgments
This work was supported by The Special Research Foundation of the National Nature Science Foundation of China (30872487)
Financial disclosure and commercial sponsorship
Each author certifies that he had no financial or commercial sponsorship to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, Xh., Xu, Lb., Liu, C. et al. Clinicopathological Characteristics of 20 Cases of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi. Dig Dis Sci 56, 252–259 (2011). https://doi.org/10.1007/s10620-010-1256-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1256-8